The Hidden Costs of Multiple Sclerosis in Italy
In Italy, researchers recently took a close look at the financial burden of multiple sclerosis (MS) on patients receiving disease-modifying therapies (DMTs). They studied 393 MS patients, mostly women around 45 years old, with a form of MS called relapsing-remitting MS (RRMS). On average, each patie